Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock

Clinical Research in Cardiology

Volumn 101, Issue 5, 2012, Pages 375-384

  Prondzinsky, Roland ^a   Unverzagt, Susanne ^a   Lemm, Henning ^a   Wegener, Nikolas Arne ^a   Schlitt, Axel ^a   Heinroth, Konstantin M ^a   Dietz, Sebastian ^a   Buerke, Ute ^a   Kellner, Patrick ^a   Loppnow, Harald ^a   Fiedler, Martin G ^b   Thiery, Joachim ^b   Werdan, Karl ^a   Buerke, Michael ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cardiogenic shock; Inflammation; Interleukins; Systemic inflammatory response

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; COUNTERPULSATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; INTRAAORTIC COUNTERPULSATION; MALE; MORTALITY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-7; INTERLEUKIN-8; INTERLEUKINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROGNOSIS; SHOCK, CARDIOGENIC;

EID: 84860835835     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0403-3     Document Type: Article

References (48)

1. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M (2010) Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 38:152-160
2. Hochman JS, Sleeper LA, Webb JG et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625-634
3. Ruiz-Bailen M, Rucabado-Aguilar L, Exposito-Ruiz M et al (2009) Cardiogenic shock in acute coronary syndrome. Med Sci Monit 15:RA57-RA66
4. Kouraki K, Schneider S, Uebis R, Tebbe U, Klein HH, Janssens U, Zahn R, Senges J, Zeymer U (2011) Characteristics and clinical outcome of 458 patients with acute myocardial infarction requiring mechanical ventilation. Results of the BEAT registry of the ALKK-study group. Clin Res Cardiol 100(3):235-239
5. Liebetrau C, Szardien S, Rixe J, Woelken M, Rolf A, Bauer T, Nef H, Möllmann H, Hamm C, Weber M (2011) Direct admission versus transfer of AMI patients for primary PCI. Clin Res Cardiol 100(3):217-225
6. Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM (2009) Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol 4:1811-1817
7. Tan J, Hua Q, Li J, Fan Z (2009) Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. Heart Vessels 24:329-334
8. Järemo P, Nilsson O (2008) Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction. Eur J Intern Med 19:330-333
9. Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B, Mury R, Bertel O, Frielingsdorf J (2008) Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 97:298-305 (Pubitemid 351725055)
10. Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, Siostrzonek P, Huber K, Heinz G (2002) Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 30:1987-1994
11. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS (2005) SHOCK Investigators. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165:1643-1650 (Pubitemid 41124160)
12. Lin WC, Lin CF, Chen CL, Chen CW, Lin YS (2010) Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp Biol Med 235:57-65
13. Prinsen JH, Baranski E, Posch H, Tober K, Gerstmeyer A (2008) Interleukin-6 as diagnostic marker for neonatal sepsis: determination of Access IL-6 cutoff for newborns. Clin Lab 54:179-183
14. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, Stuttmann R, Speichermann N, Verner L, Werdan K (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsisassociated left ventricular dysfunction. Intensive Care Med 29:1696-1702 (Pubitemid 37373812)
15. Altman DA (1991) Practical statistics for medical research. Chapman & Hall, London
16. Sauerbrei W, Madjar H, Prömpeler HJ (1998) Differentiation of benign and malignant breast tumours by logistic regression and a classification tree using Doppler flow signals. Methods Inf Med 37:226-234 (Pubitemid 28450058)
17. Känel R, Carney RM, Zhao S, Whooley MA (2011) Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study. Clin Res Cardiol 100(3):241-247
18. Villar J, Maca-Meyer N, Pérez-Méndez L, Flores C (2004) Bench-to-bedside review: understanding genetic predisposition to sepsis. Crit Care 8:180-189 (Pubitemid 38735697)
19. Fitting C, Cheval C, Losser MR, Carlet J, Payen D, Foster K, Cavaillon JM (1997) Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect Immun 65:865-871 (Pubitemid 27087983)
20. Zeerleder S, Caliezi C, van Mierlo G, Eerenberg-Belmer A, Sulzer I, Hack CE, Wuillemin WA (2003) Clin Diagn Lab Immunol 10:529-535
21. Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, Moutardier V, Blache JL (2005) Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94:767-773 (Pubitemid 40753992)
22. Weber GF, Schlautkö tter S, Kaiser-Moore S, Altmayr F, Holzmann B, Weighardt H (2007) Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun 75:1690-1697 (Pubitemid 46559433)
23. Torre-Amnione Kapadia S, Lee J et al (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711
24. Werra ID (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factro receptors, and procalcitonin concentrations: comparison in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607-613
25. Neumann FJ, Ott I, Gawaz M et al (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92:748-755
26. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, Dhainaut JF, Cavaillon JM (2002) Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106:562-568 (Pubitemid 34827705)
27. Kohsaka S, Menon V, Iwata K, Lowe A, Sleeper LA, Hochman JS (2007) SHOCK investigators. Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study). Am J Cardiol 99:802-804 (Pubitemid 46365600)
28. Kadokami T, McTiernan C, Kubota T, Frye C, Bounoutas G, Robbins P, Watkins S, Feldman A (2001) Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression. Am J Physiol Heart Circ Physiol 280:H2281-H2291
29. Miettinen JA, Ylitalo K, Hedberg P, Kervinen K, Niemelä M, Säily M, Koistinen P, Savolainen ER, Ukkonen H, Pietilä M, Airaksinen KE, Knuuti J, Vuolteenaho O, Mäkikallio TH, Huikuri HV (2011) Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction. Clin Res Cardiol 100(4):317-325
30. Prondzinsky R, Müller-Werdan U, Pilz G, Witthaut R, Stabenow I, Werdan K, Zerkowski HR (1997) Systemic inflammatory reactions to extracorporeal therapy measures (II): cardiopulmonary bypass. Wien Klin Wochenschr 109:346-353 (Pubitemid 27267232)
31. Prondzinsky R, Knüpfer A, Loppnow H, Redling F, Lehmann DW, Stabenow I, Witthaut R, Unverzagt S, Radke J, Zerkowski HR, Werdan K (2005) Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg 129:760-766 (Pubitemid 40487875)
32. Kilger E, Heyn J, Beiras-Fernandez A, Luchting B, Weis F (2011) Stress doses of hydrocortisone reduce systemic inflammatory response in patients undergoing cardiac surgery without cardiopulmonary bypass. Minerva Anestesiol 77:268-274
33. Steinvil A, Berliner S, Shapira I, Rogowski O, Justo D, George J, Halkin A, Keren G, Finkelstein A, Banai S, Arbel Y (2010) Time to rheology in acute myocardial infarction: inflammation and erythrocyte aggregation as a consequence and not necessarily as precursors of the disease. Clin Res Cardiol 99(10):651-656
34. Jung C, Rödiger C, Fritzenwanger M, Schumm J, Lauten A, Figulla HR, Ferrari M (2009) Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock. Clin Res Cardiol 98(8):469-475
35. Munsterman LD, Elbers PW, Ozdemir A, van Dongen EP, van Iterson M, Ince C (2010) Withdrawing intra-aortic balloon pump support paradoxically improves microvascular flow. Crit Care 14(4):R161
36. Osuchowski MF, Welch K, Siddiqui J, Remick DG (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177:1967-1974 (Pubitemid 44092537)
37. Schröder J, Kahlke V, Staubach KH, Zabel P, Stüber F (1998) Gender differences in human sepsis. Arch Surg 133:1200-1205 (Pubitemid 28516271)
38. Arranz L, Lord JM, De la Fuente M (2010) Preserved ex vivo inflammatory status and cytokine responses in naturally longlived mice. Age (Dordr) 32:451-466
39. Agarwal S, Busse PJ (2010) Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol 104:183-190
40. Wong CP, Magnusson KR, Ho E (2010) Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp Gerontol 45:163-169
41. Schmidt C, Höcherl K, Kurt B, Moritz S, Kurtz A, Bucher M (2010) Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock. Cytokine 49:30-38
42. Cha J, Wang Z, Ao L et al (2008) Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 85:1678-1685 (Pubitemid 351608179)
43. Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, Ruzyllo W, Werdan K, Geppert A, Dzavik V, Van de Werf F, Hochman JS (2009) TRIUMPH investigators. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 158:680-687
44. Youssef AA, Chang LT, Hang CL, Wu CJ, Cheng CI, Yang CH, Sheu JJ, Chai HT, Chua S, Yeh KH, Yip HK (2007) Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J 71:703-708 (Pubitemid 46683361)
45. Yamamoto T, Terajima K, Kato K, Iwasaki YK, Miyagi Y, Sato N, Takeda S, Tanaka K, Takano T (2006) Transient leukocytopenia associated with a steep surge of pro-inflammatory cytokines in a patient with severe cardiogenic pulmonary edema. Intern Med 45:1153-1155 (Pubitemid 44773966)
46. Buerke M, Murohara T, Skurk C et al (1995) Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci 92:8031-8035
47. Rupprecht HJ, vom Dahl J, Terres W et al (2000) Cardioprotective effects of the Na?/H? exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 101:2902-2908 (Pubitemid 30415879)
48. Werdan K, Pilz G, Bujdoso O et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35:2693-2701 (Pubitemid 350175763)